Target intelligence / Profile preview

Novel transcript, antisense to PARN

Molecular classification
Other, long non-coding RNA, antisense RNA
01

Overview

Novel transcript, antisense to PARN" (ENSG00000308270, LOC105371094) is an antisense long non-coding RNA (lncRNA) transcribed from the genomic region opposite the poly(A)-specific ribonuclease (PARN) gene. Antisense lncRNAs are a class of non-coding RNAs that typically regulate the expression, stability, or splicing of overlapping or neighboring genes through mechanisms such as transcriptional interference, the formation of double-stranded RNA, RNA masking, or recruitment of chromatin-modifying complexes[1][5]. While specific information about this antisense transcript's unique biological or disease roles is not reported, natural antisense transcripts frequently play regulatory roles in gene expression and may participate in fine-tuning responses to cellular stress or developmental cues. However, no direct disease association, drug interaction, or established biomarker or target use has been reported for this specific transcript.

Other names
ENSG00000308270LOC105371094
02

Biological functions

Regulation of gene expression (by antisense interference)RNA maskingChromatin remodelingDouble-stranded RNA-dependent mechanisms (such as RNAi)Possible modulation of transcript stability and splicing
03

Disease associations

Other (general roles are possible in gene regulation and chromatin state, not specifically associated with a disorder for this transcript)

Beyond the preview

Go deeper on Novel transcript, antisense to PARN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to PARN.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call